Inter-arm blood pressure difference: Consecutive versus simultaneous measurements in treated and controlled hypertense patients

被引:0
|
作者
Delucchi, A. [1 ]
Fernandez, D. [1 ]
Sorini, M. [1 ]
Reisin, P. [1 ]
Scarabino, M. [1 ]
Rodriguez, P. [1 ]
机构
[1] Sanat Municipal Dr Julio Mendez, Secc Hipertens Arterial, Buenos Aires, Argentina
来源
HIPERTENSION Y RIESGO VASCULAR | 2024年 / 41卷 / 04期
关键词
Arterial hypertension; Inter-arm difference; Reproducibility; Simultaneous measurements; EUROPEAN-SOCIETY; MANAGEMENT;
D O I
10.1016/j.hipert.2024.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The inter-arm difference (IAD) of systolic blood pressure (SBP) is associated with higher cardiovascular risk. We compared simultaneous and consecutive recordings in measuring IAD of SBP, and evaluated reproducibility between visits. 143 hypertensive patients (63.8 +/- 9.5 years, 51.7% women) treated and controlled with stable antihypertensive medication for a period of > 3 months were included. Blood pressure (BP) in both arms was measured simultaneously and consecutively with an automatic oscillometric device, in two visits. The IAD of the simultaneous SBP was significantly lower compared to the consecutive one, both in the first (3.51 +/- 4.1 vs. 4.40 +/- 3.7 mmHg; P < .01) and in the second visit (3.62 +/- 3.5vs. 5.69 +/- 5.1 mmHg; P < .001). When the IAD of SBP was categorized as > 10 or < 10 mmHg, the reproducibility between visits was insignificant in both simultaneous measurements and consecutive measurements. The frequency of initial dominance was similar between the left and right arm in simultaneous ones (46.2 vs. 43.3%), and greater in the right arm in consecutive ones (55.2 vs. 38.5). The persistence of dominance between both visits was significantly higher when SBP was measured simultaneously (54.4% vs. 45.5%; P < .01). Our study shows that to define the arm with the highest BP, simultaneous measurements are preferable. In treated and controlled hypertensive patients, the poor persistence of initial dominance between visits requires us to review the recommendation of recording, during follow-up, the BP in the arm where it was highest on the first visit. (c) 2024 SEHLELHA. Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 35 条
  • [31] Bilateral sphenopalatine ganglion block reduces blood pressure in never treated patients with essential hypertension. A randomized controlled single-blinded study
    Triantafyllidi, Helen
    Arvaniti, Chrysa
    Schoinas, Antonios
    Benas, Dimitris
    Vlachos, Stefanos
    Palaiodimos, Leonidas
    Pavlidis, George
    Ikonomidis, Ignatios
    Batistaki, Chrysanthi
    Voumvourakis, Costas
    Lekakis, John
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 250 : 233 - 239
  • [32] Standard Versus Intensive Blood Pressure Control in Acute Ischemic Stroke Patients Successfully Treated With Endovascular Thrombectomy: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
    Park, Hyungjong
    Sohn, Sung-Il
    Leem, Gwang Hyun
    Kim, Minho
    Kim, Yun Hak
    Song, Tae-Jin
    JOURNAL OF STROKE, 2024, 26 (01) : 54 - 63
  • [33] Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial
    Cohen, Debbie L.
    bloedon, LeAnne T.
    Rothman, Rand L.
    Farrar, John T.
    Galantino, Mary Lou
    Volger, Sheri
    Mayor, Christine
    Szapary, Phillipe O.
    Townsend, Raymond R.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 : 1 - 8
  • [34] Simultaneous control of blood glucose, blood pressure, and lipid among drug-treated Type 2 diabetes patients from Shaanxi province, North-Western China: A multicenter study
    Xu, S.
    Sun, F.
    Xu, W.
    Jiao, K.
    Shi, B.
    Xie, X.
    Wang, Y.
    Zhu, M.
    Ji, Q.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2016, 19 (06) : 784 - 792
  • [35] Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study
    Weber, Michael A.
    Mansfield, Traci A.
    Cain, Valerie A.
    Iqbal, Nayyar
    Parikh, Shamik
    Ptaszynska, Agata
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (03) : 211 - 220